Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Goetz

Showing results (331-340 of 754) with videos related to

Pageof 76
Sort By:
Neurology|February 11, 2000
Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's diseaseK Kompoliti, Q E Wang, C G Goetz, et al.
Neurology|July 1, 1979
Amphetamine-induced hypersensitivity in guinea pigsW J Weiner, C G Goetz, P A Nausieda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 1997
Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's diseaseC G Goetz, G T Stebbins, L M Blasucci, et al.
Annals of Internal Medicine|March 1, 1978
Respiratory dyskinesias: extrapyramidal dysfunction and dyspneaW J Weiner, C G Goetz, P A Nausieda, et al.
Archives of Neurology|May 10, 2006
The malignant course of "benign hallucinations" in Parkinson diseaseChristopher G Goetz, Wenqing Fan, Sue Leurgans, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2007
Levodopa-induced dyskinesiasGiovanni Fabbrini, Jonathan M Brotchie, Francisco Grandas, et al.
Experimental Neurology|March 1, 1997
Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recoveryJ H Kordower, C G Goetz, T B Freeman, et al.
Advances in Neurology|January 1, 1988
The predictive value of acute antimuscarinic drugs for the chronic efficacy of antimuscarinic drugs in adults with focal dystoniaC M Tanner, R S Wilson, C G Goetz, et al.
Clinical Neuropharmacology|January 1, 1982
Tardive dyskinesia: pharmacology and clinical implicationsC G Goetz, W J Weiner, P A Nausieda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 2008
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodiesJennifer G Goldman, Christopher G Goetz, Melanie Brandabur, et al.
Pageof 76

Showing results (331-340 of 754) with videos related to

Sort By:
Pageof 76
Neurology|February 11, 2000
Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's diseaseK Kompoliti, Q E Wang, C G Goetz, et al.
Neurology|July 1, 1979
Amphetamine-induced hypersensitivity in guinea pigsW J Weiner, C G Goetz, P A Nausieda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 1997
Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's diseaseC G Goetz, G T Stebbins, L M Blasucci, et al.
Annals of Internal Medicine|March 1, 1978
Respiratory dyskinesias: extrapyramidal dysfunction and dyspneaW J Weiner, C G Goetz, P A Nausieda, et al.
Archives of Neurology|May 10, 2006
The malignant course of "benign hallucinations" in Parkinson diseaseChristopher G Goetz, Wenqing Fan, Sue Leurgans, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2007
Levodopa-induced dyskinesiasGiovanni Fabbrini, Jonathan M Brotchie, Francisco Grandas, et al.
Experimental Neurology|March 1, 1997
Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recoveryJ H Kordower, C G Goetz, T B Freeman, et al.
Advances in Neurology|January 1, 1988
The predictive value of acute antimuscarinic drugs for the chronic efficacy of antimuscarinic drugs in adults with focal dystoniaC M Tanner, R S Wilson, C G Goetz, et al.
Clinical Neuropharmacology|January 1, 1982
Tardive dyskinesia: pharmacology and clinical implicationsC G Goetz, W J Weiner, P A Nausieda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 2008
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodiesJennifer G Goldman, Christopher G Goetz, Melanie Brandabur, et al.
Pageof 76